CIBIS III trial: Bisoprolol treatment for CHF leads to 46% reduction in sudden death after one year.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D017298:Bisoprolol / Q000008:administration & dosage*; D002908:Chronic Disease; D016757:Death, Sudden, Cardiac / Q000209:etiology; D018572:Disease-Free Survival; D004656:Enalapril / Q000008:administration & dosage; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008297:Male; D011446:Prospective Studies; D015996:Survival Rate
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D017298:Bisoprolol